Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet

Published:2012-12-04 Issue:8 Volume:37 Page:1064-1070
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Brozinick J T,Hawkins E,Hoang Bui H,Kuo M-S,Tan B,Kievit P,Grove K

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/ijo2012191.pdf

Reference58 articles.

1. Bloomgarden ZT . World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease. Diabetes Care 2011; 34: e140–e145.

2. Summers SA . Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 2010; 21: 128–135.

3. Yang G, Badeanlou L, Bielawski J, Roberts AJ, Hannun YA, Samad F . Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009; 297: E211–E224.

4. Unger RH . Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159–5165.

5. Summers SA, Nelson DH . A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing’s syndrome. Diabetes 2005; 54: 591–602.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceramides—Emerging Biomarkers of Lipotoxicity in Obesity, Diabetes, Cardiovascular Diseases, and Inflammation;Diseases;2024-08-23

2. Ceramides are fuel gauges on the drive to cardiometabolic disease;Physiological Reviews;2024-07-01

3. Obesity promotes fumonisin B1 hepatotoxicity;Science of The Total Environment;2023-09

4. Comparative characteristics of newly diagnosed adult diabetic patients: a pilot study.;Acta Poloniae Pharmaceutica - Drug Research;2023-07-28

5. Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes;Cardiovascular Diabetology;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3